-
Innovation Ranking
Innovation Ranking – Under Armour Inc
Under Armour Inc (Under Armour) is a developer, marketer, and distributor of apparel, footwear, and accessories. The company provides products under multiple price levels to cater to diverse customer categories. It sells products through retail stores, direct-to-consumer sales channels, e-commerce websites, and product licensing worldwide. Under Armour undertakes the wholesale distribution of products to national, regional, independent, and specialty retailers. The company markets its products under UA, Armour, Heatgear, Coldgear, Protect This House, I WILL, Armour, Armour Fleece and Armour...
-
Company Insights
Under Armour, Inc. – Digital Transformation Strategies
Under Armour Digital Transformation Strategies Overview Under Armour, Inc. (Under Armour) is leveraging several emerging technologies, including AI, cloud, augmented reality, 3D printing, and metaverse among others to improve business operations, enhance customer service and develop better products. The annual ICT spending of Under Armour was estimated at $70.1 million for 2023. A major share of this spending is earmarked for acquiring software, ICT services and network and communications from vendors. Under Armour develops, markets, and distributes branded performance footwear,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Thyroid in Hypothyroidism
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Thyroid in Hypothyroidism report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Thyroid in Hypothyroidism Drug Details: Armour thyroid is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-22P in Liver Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-22P in Liver Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-22P in Liver Cancer Drug Details: SL-22P is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-22P in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-22P in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-22P in Solid Tumor Drug Details: SL-22P is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-22P in Refractory Brain Metastasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-22P in Refractory Brain Metastasis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-22P in Refractory Brain Metastasis Drug Details: SL-22P is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OBX-115 in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OBX-115 in Metastatic Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OBX-115 in Metastatic Melanoma Drug Details: OBX-115 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OBX-115 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OBX-115 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OBX-115 in Solid Tumor Drug Details: OBX-115 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OBX-115 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OBX-115 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OBX-115 in Non-Small Cell Lung Cancer Drug Details: OBX-115...
-
Sector Analysis
NewNCAA Basketball Championships 2024 – Event Analysis
An analysis of the recent 2024 NCAA Basketball Championships , including a look at its sponsorship portfolio, broadcasters, prize money, ticketing and attendance. CBS, which broadcasted the men’s title game has a 13-year agreement with the NCAA worth $771.43 million a year. According to Nielsen, the men’s title game between the University of Connecticut and Purdue University captured an audience of 14.82 million viewers. The women’s championship game between the University of South Carolina and the University of Iowa brought...